The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

Share Price Information for Surface Transforms (SCE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.275
Bid: 1.25
Ask: 1.30
Change: 0.00 (0.00%)
Spread: 0.05 (4.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.275
SCE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing

8 Dec 2009 07:00

RNS Number : 7036D
Surface Transforms PLC
08 December 2009
 



Surface Transforms Plc

("Surface Transforms" or "the Company")

 Placing 

Introduction

The Company today announces that it has conditionally placed with certain existing shareholders, including directors and senior management of the Company, 800,000 new ordinary shares ("Placing Shares") of 1p each ("Ordinary Shares") at a price of 10p per share thereby raising gross proceeds of £80,000 (the "Placing"). The proceeds will provide specific capital to finance the investment in additional working capital related to the Company's carbon vapour infiltration (CVI) process. The CVI manufacturing stage is a key part of the Company's proprietary process for manufacturing silicon carbide brake discs and components.

The Placing Shares will represent approximately 3.29 per cent of the Company's enlarged share capital.

Background to and reasons for the Placing

A number of existing shareholders had expressed interest in further investment in the Company and this coincided with a need to increase the levels of inventory of 'mission critical' components and spares relating to the CVI process. The newly commissioned CVI process is a critical stage in the manufacture of silicon carbide components and process downtime is minimised by having 'mission critical' inventory and spares available at all times.

Issue of New Shares

The Placing is solely conditional upon Admission of the Placing Shares to AIM.

Application will be made to the London Stock Exchange for the Placing Shares to be admitted to trading on AIM. It is expected that such Admission will become effective and that dealings will commence on or around 15th December 2009.

The Placing Shares will, when issued, rank pari passu in all respects with the existing Ordinary Shares, including the right to receive dividends and other distributions declared following Admission. 

Directors' Participation in the Placing

The following Directors participated in the Placing and their holdings are detailed below:

Name

Number of Existing Ordinary Shares

Percentage of existing voting share capital

Number of Shares following the Placing

Percentage of existing voting share capital following the Placing

Dr.Kevin Johnson

79,750

0.34%

104,750

0.43%

Kenneth Baker

115,000

0.49%

215,000

0.88%

Richard Gledhill

6,828,723

29.00%

7,072,223

29.05%

In addition, two members of the senior management team also participated in the Placing and in total directors and management of the Company invested £44,500 of the £80,000 Placing funds.

Total Voting Rights

For the purposes of the Disclosure and Transparency Rules, the Company's total issued share capital following the completion of the Placing will consist  of 24,347,328 ordinary shares of 1p each with one voting right per share. There are no shares held in treasury. 

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

Enquiries:

Surface Transforms Plc
+44 (0) 151 356 2141
Dr. Kevin Johnson, CEO
 
Geoff Hall, Company Secretary
 
 
 
Seymour Pierce Limited
+ 44 (0) 207 107 8000
Corporate Finance
 
Nandita Sahgal
 
Christopher Wren
 
 
 
Corporate Broking
 
Paul Jewell
 

 

Seymour Pierce Limited, which is regulated by the Financial Services Authority and is a member of the London Stock Exchange, is acting as nominated adviser and broker exclusively for the Company in connection with the Placing. Its responsibilities as the Company's nominated adviser under the AIM Rules are owed solely to the London Stock Exchange and are not owed to the Company or to any Director or any other person in respect of his decision to acquire ordinary shares in the Company in reliance on any part of this announcement. No representation or warranty, express or implied, is made by Seymour Pierce Limited as to any of the contents of this announcement for which the Directors and the Company are responsible (without limiting the statutory rights of any person to whom this announcement is issued). Seymour Pierce Limited has not authorised the contents of, or any part of, this announcement, and no liability whatsoever is accepted by Seymour Pierce Limited for the accuracy of information or opinions contained in this announcement or for the omission of any material information. Seymour Pierce Limited will not be offering advice and will not otherwise be responsible for providing customer protections to recipients of this announcement in respect of the Placing or any acquisition of shares in the Company.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEZDLFBKLBLFBL
Date   Source Headline
16th Dec 202112:34 pmRNSMichael Cunningham purchase of shares
16th Dec 20217:00 amRNSAnnouncement of contract wins with OEM 6
14th Dec 20217:00 amRNSTrading and operations update
11th Nov 20217:00 amRNSDirector/PDMR Shareholding
10th Nov 20217:00 amRNSDirector/PDMR Shareholding
20th Sep 20214:35 pmEQSHardman & Co Research : Hardman Talks Video | Surface Transforms Management Presentation
13th Sep 20217:00 amRNSHalf-year Financial Report
2nd Sep 20217:01 amRNSNew manufacturing strategy
2nd Sep 20217:00 amRNSContract Award from OEM 5
17th Aug 20217:00 amRNSContract award from OEM 10 and notice of results
8th Jul 20217:00 amRNSTrading and operations update
5th Jul 20213:00 pmRNSExercise of options
9th Jun 20218:45 amEQSHardman & Co Research : Hardman Talks Video| Surface Transforms Management Presentation
2nd Jun 20219:43 amRNSResult of Annual General Meeting
28th May 202111:18 amRNSExercise of Options
27th May 202111:51 amRNSMeet the Directors and Q&A
25th May 20217:00 amRNSDirector Dealing
20th May 20219:30 amEQSHardman & Co Research : Hardman Talks Video Event | Surface Transforms - Q&A with the Board
13th May 20217:00 amRNSDirector Dealing
4th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
22nd Apr 20215:38 pmRNSPDMR Dealing
22nd Apr 20215:33 pmRNSDirector Dealing
19th Apr 20215:46 pmRNSExercise of Options
13th Apr 20217:00 amRNSDirector Dealing
12th Apr 20217:00 amRNSPreliminary Results and Notice of AGM
24th Mar 20217:00 amRNS£1 million loan agreement with LCRCA
15th Mar 20213:55 pmEQSHardman & Co Research: Surface Transforms (SCE): Everything has come together
15th Mar 20217:00 amRNSRetirement of NED & update on preliminary results
5th Mar 20217:00 amRNSAppointment of non-executive directors
24th Feb 20217:00 amRNSGrant of Options
18th Feb 20213:15 pmRNSCorrection: Exercise of Options
18th Feb 20218:54 amRNSExercise of Options
15th Feb 20217:00 amRNSPDMR Dealing
12th Feb 202111:31 amRNSDirector Dealing
11th Feb 20212:39 pmRNSHolding(s) in Company
10th Feb 202112:37 pmRNSHolding(s) in Company
10th Feb 202111:14 amRNSExercise of Options
10th Feb 202111:10 amRNSHolding(s) in Company
8th Feb 202110:35 amRNSResult of General Meeting
8th Feb 20217:00 amRNSResult of Over-Subscribed Open Offer
2nd Feb 20212:30 pmEQSHardman & Co Research : Hardman Talks video release - Surface Transforms management discuss fundraising
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
22nd Jan 20217:00 amRNSOnline investor presentation
20th Jan 20218:09 amRNSResult of Placing and Subscription, & Notice of GM
19th Jan 20215:35 pmRNSProposed Placing, Subscription and Open Offer
8th Jan 20215:13 pmRNSReplacement announcement - director dealings
5th Jan 20217:00 amRNSTrading, OEM Pipeline & Operations Update
30th Nov 20209:48 amRNSDirector Dealing
19th Nov 20205:59 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.